Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 62Myelodysplastic Syndromes 27Leukemia 13Leukemia, Myelomonocytic, Chronic 12Congenital Abnormalities 9Recurrence 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Myeloproliferative Disorders 8Primary Myelofibrosis 6Thrombocythemia, Essential 4Polycythemia Vera 4Neoplasms 4Melanoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Head and Neck Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Burkitt Lymphoma 3Blast Crisis 3Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Sarcoma 2Neuroblastoma 2Neoplasm Metastasis 2Myelodysplastic-Myeloproliferative Diseases 2Mesothelioma, Malignant 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2

Interventions

venetoclax 1spartalizumab 1sabatolimab 1lintuzumab 1fludarabine 1Sertraline 1Melphalan 1Lenalidomide 1Decitabine 1Biopsy 1Azacitidine 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Preleukemia × Decitabine × Clear all
NCT03066648 2025-05-18

Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS

Novartis

Phase 1 Completed
241 enrolled
MyeloidOther hematologic neoplasm

Bone Marrow Diseases, Hematologic Diseases, Leukemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Preleukemia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡